ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Passive Equities

      First Trust Nasdaq Pharmaceuticals ETF

      The First Trust Nasdaq Pharmaceuticals ETF (the ¡°Fund¡±) seeks investment results that correspond generally to the price and yield (before the Fund¡¯s fees and expenses) of an equity index called the Nasdaq US Smart PharmaceuticalsTM Index (the ¡°Index¡±).

      $28.26

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Nasdaq Pharmaceuticals ETF FTXH
      Fund Size
      $15.2M
      Dividend
      1.6%
      Fees
      0.60%
      Total Stock Market Index Fund VTSAX
      Fund Size
      $1.7T
      Dividend
      -
      Fees
      -
      Total Stock Market Index Fund VTI
      Fund Size
      $1.7T
      Dividend
      1.2%
      Fees
      0.03%
      500 Index Fund VFIAX
      Fund Size
      $1.49T
      Dividend
      -
      Fees
      -
      500 Index Fund VOO
      Fund Size
      $1.49T
      Dividend
      1.2%
      Fees
      0.03%
      View 1315 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $139B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 2.25 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.5668
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 38.73
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -30.2
      Profitable Companies 77
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 164.87
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.14
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 11.48
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 52.25
      Enterprise Value to Revenue Enterprise value divided by revenue 5.38
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.11
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 14.81%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 65.27%
      Return on Assets Indicates a company's profitability in relation to its total assets. 28.18%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 38.70%

      Industries

      Healthcare 94.1%
      Finance 2.0%
      Industrials 2.0%
      N/A 2.0%

      Market cap

      Micro Cap 2%
      Small Cap 1%
      Mid Cap 22%
      Large Cap 50%
      Mega Cap 26%

      51 Investments

      P/E-Ratio
      Total Investment
      Weight
      Bristol-Myers Squibb Co logo

      BMY - Manufacturing

      Bristol-Myers Squibb Co

      P/E-Ratio
      -16.7
      Total Investment
      $1.16M
      Weight
      7.6%
      Johnson & Johnson logo

      JNJ - Manufacturing

      Johnson & Johnson

      P/E-Ratio
      18.9
      Total Investment
      $1.14M
      Weight
      7.5%
      AbbVie Inc logo

      ABBV - Manufacturing

      AbbVie Inc

      P/E-Ratio
      98.9
      Total Investment
      $1.13M
      Weight
      7.5%
      Merck & Co Inc logo

      MRK - Manufacturing

      Merck & Co Inc

      P/E-Ratio
      12.9
      Total Investment
      $1.1M
      Weight
      7.3%
      Pfizer Inc logo

      PFE - Manufacturing

      Pfizer Inc

      P/E-Ratio
      13.1
      Total Investment
      $1.08M
      Weight
      7.2%
      Amgen Inc logo

      AMGN - Manufacturing

      Amgen Inc

      P/E-Ratio
      23.4
      Total Investment
      $572k
      Weight
      3.8%
      Zoetis Inc logo

      ZTS - Manufacturing

      Zoetis Inc

      P/E-Ratio
      26.7
      Total Investment
      $557k
      Weight
      3.7%
      Gilead Sciences Inc logo

      GILD - Manufacturing

      Gilead Sciences Inc

      P/E-Ratio
      22.3
      Total Investment
      $554k
      Weight
      3.7%
      Biogen Inc logo

      BIIB - Manufacturing

      Biogen Inc

      P/E-Ratio
      12.6
      Total Investment
      $551k
      Weight
      3.6%
      United Therapeutics Corp logo

      UTHR - Manufacturing

      United Therapeutics Corp

      P/E-Ratio
      11.1
      Total Investment
      $545k
      Weight
      3.6%
      Viatris Inc logo

      VTRS - Finance and Insurance

      Viatris Inc

      P/E-Ratio
      -3.6
      Total Investment
      $534k
      Weight
      3.5%
      Regeneron Pharmaceuticals Inc logo

      REGN - Manufacturing

      Regeneron Pharmaceuticals Inc

      P/E-Ratio
      13.7
      Total Investment
      $513k
      Weight
      3.4%
      Eli Lilly & Co logo

      LLY - Manufacturing

      Eli Lilly & Co

      P/E-Ratio
      47.7
      Total Investment
      $507k
      Weight
      3.3%
      Jazz Pharmaceuticals PLC logo

      JAZZ - Manufacturing

      Jazz Pharmaceuticals PLC

      P/E-Ratio
      -19.3
      Total Investment
      $489k
      Weight
      3.2%
      Organon & Co logo

      OGN - Manufacturing

      Organon & Co

      P/E-Ratio
      4.4
      Total Investment
      $408k
      Weight
      2.7%
      Charles River Laboratories Int logo

      CRL - Professional, Scientific, and Technical Services

      Charles River Laboratories Int

      P/E-Ratio
      -115.9
      Total Investment
      $295k
      Weight
      2.0%
      Exelixis Inc logo

      EXEL - Professional, Scientific, and Technical Services

      Exelixis Inc

      P/E-Ratio
      16.9
      Total Investment
      $285k
      Weight
      1.9%
      Medpace Holdings Inc logo

      MEDP - Professional, Scientific, and Technical Services

      Medpace Holdings Inc

      P/E-Ratio
      33.5
      Total Investment
      $262k
      Weight
      1.7%
      Elanco Animal Health Inc logo

      ELAN - Manufacturing

      Elanco Animal Health Inc

      P/E-Ratio
      21.0
      Total Investment
      $243k
      Weight
      1.6%
      Illumina Inc logo

      ILMN - Manufacturing

      Illumina Inc

      P/E-Ratio
      12.6
      Total Investment
      $235k
      Weight
      1.6%
      Halozyme Therapeutics Inc logo

      HALO - Manufacturing

      Halozyme Therapeutics Inc

      P/E-Ratio
      15.9
      Total Investment
      $229k
      Weight
      1.5%
      Neurocrine Biosciences Inc logo

      NBIX - Manufacturing

      Neurocrine Biosciences Inc

      P/E-Ratio
      39.7
      Total Investment
      $198k
      Weight
      1.3%
      BioMarin Pharmaceutical Inc logo

      BMRN - Manufacturing

      BioMarin Pharmaceutical Inc

      P/E-Ratio
      17.0
      Total Investment
      $197k
      Weight
      1.3%
      Alkermes PLC logo

      ALKS - Manufacturing

      Alkermes PLC

      P/E-Ratio
      13.7
      Total Investment
      $167k
      Weight
      1.1%
      Corcept Therapeutics Inc logo

      CORT - Manufacturing

      Corcept Therapeutics Inc

      P/E-Ratio
      54.8
      Total Investment
      $147k
      Weight
      1.0%
      HoMEÔçÒÒŮѸÀ×